![](https://investorshub.advfn.com/uicon/507416.png?cb=1538015923)
Saturday, January 22, 2022 6:40:17 AM
Analyst Coverage Mackie Research Capital Echelon Wealth Partners Target Price “$0.80” by Mackie Research “$0.50” by Echelon Wealth
TREATMENT FOR VARIOUS CANCERS Planning on initiating Phase 1b study for other cancer indications. Strong upside for growth and valuation.
PowerPoint Presentation Sept 2021
JMO, maybe, maybe not.
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM